Two case reports of FGF23-induced hypophosphatemia in Childhood Biliary Atresia

21Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Cholestatic liver disease has long been associated with childhood rickets, secondary to impaired absorption of fat-soluble vitamin D. Elevated serum levels of fibroblast growth factor 23 (FGF23), secondary to genetic defects or tumor-induced osteomalacia, causes hypophosphatemic rickets in childhood. We present 2 infants with end-stage liver disease due to biliary atresia (BA) who developed hypophosphatemia with renal phosphate wasting. Serum FGF23 levels were elevated more than 8 times the upper limit of normal, and the older infant showed radiographic evidence of rickets. Both infants required large supplements of phosphate in addition to calcitriol. Following liver transplantation, FGF23 normalized in both patients and phosphate and calcitriol supplementation were discontinued. Immunohistochemistry revealed ectopic overexpression of FGF23 by hepatocytes in the BA liver. These observations highlight a unique cause of hypophosphatemic rickets in childhood and suggest the need for further investigation into the relationship between BA and other cholestatic disorders, and bone metabolism.

Cite

CITATION STYLE

APA

Wasserman, H., Ikomi, C., Hafberg, E. T., Miethke, A. G., Bove, K. E., & Backeljauw, P. F. (2016). Two case reports of FGF23-induced hypophosphatemia in Childhood Biliary Atresia. Pediatrics, 138(2). https://doi.org/10.1542/peds.2015-4453

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free